Bayer Aktiengesellschaft
Tažením v grafu vyberte úsek a zobrazí se procentuální změna.Tažením dvěma prsty vyberte úsek a zobrazí se procentuální změna.
Kapitálová struktura
- Tržní kapitalizace
- 48,51 mld. €
- Enterprise Value
- 81,98 mld. €
- Hotovost
- 5,08 mld. €
- Celkový dluh
- 38,43 mld. €
- Čistý dluh
- 33,35 mld. €
Valuace (TTM)
- P/E
- —
- P/E (fwd)
- 10,23×
- P/FCF
- 23,35×
- FCF výnos
- 4,28 %
- EV/EBITDA
- 8,09×
- P/S
- —
- P/B
- 1,64×
- Beta
- 0,83
Marže (TTM)
- Hrubá marže
- 60,46 %
- EBITDA marže
- 22,33 %
- Provozní marže
- 9,19 %
- Čistá marže
- -3,83 %
- FCF marže
- 4,58 %
Ziskovost a růst
- ROE (rentabilita kapitálu)
- -5,69 %
- Růst tržeb (YoY)
- 1,20 %
- Růst zisku (YoY)
- —
Dividenda
- Dividendový výnos
- 0,22 %
- Roční dividenda
- 0,11 €
- Výplatní poměr
- 163,27 %
- Datum ex-dividendy
- 2026-04-27
52týdenní rozpětí
- Aktuální
- 49,38 €
- Pozice v pásmu
- 84 %
- Nad ročním minimem
- +91,54 %
- Pod ročním maximem
- -8,42 %
Cena v kontextu
- Historické maximum
- 143,87 €
- Datum maxima
- 10. 4. 2015
- Zpět na maximum
- +191,36 %
- 200denní průměr
- 42,60 €
- Odchylka od průměru
- +15,92 %
O společnosti
WebBayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Vedení společnosti
- Mr. Stefan OelrichPresident of the Pharmaceuticals Division & Member of the Board of Management
- Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board
- Dr. Judith HartmannCFO & Member of Management Board
- Mr. Rodrigo SantosMember of Management Board, Head of the Crop Science Division & President of Crop Science Division
- Mr. Julio TrianaMember of Management Board & President of Consumer Health Division
- Mr. Alex BuschermohleChief Information Officer, Head-Digital Transformation & IT-Crop Science Division
- Ms. Jana Marlen AckermannHead of the Investor Relations
- Mr. Bill DoderoGeneral Counsel and Senior VP of Law Patents & Compliance
- Mr. Michael PreussHead of Communications, Government Relations and Corporate Brand